Self-Management in Adults With Asthma or COPD
A Single-Assessor-Blinded Randomized Controlled Trial
1 other identifier
interventional
104
1 country
1
Brief Summary
This study is a single-blind (evaluator-blind), parallel-group randomized controlled trial comparing two approaches to home-based pulmonary rehabilitation self-management training in individuals with chronic respiratory disease (asthma or COPD): brochure-based and video-animation-based. The topic is current and clinically relevant; the comparison of digital health literacy and patient education materials is a relatively understudied area in the literature. Sample size calculations were performed, the CONSORT 2010 guidelines were followed, and the statistical method (mixed-design ANOVA) is appropriate to the study question.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 28, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
CompletedFirst Submitted
Initial submission to the registry
July 28, 2026
CompletedFirst Posted
Study publicly available on registry
August 3, 2026
CompletedAugust 3, 2026
July 1, 2026
3 months
July 28, 2026
July 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Chronic Disease Self-Management Scale
Self-management was evaluated using the Chronic Disease Self-Management Scale (CDSMS), which comprises 23 items across four subscales: Self-Stigmatization (7 items), Coping with Stigma (5 items), Healthcare Effectiveness (5 items), and Treatment Adherence (6 items). The Turkish adaptation of the scale has shown strong internal consistency, with Cronbach's alpha coefficients between 0.715 and 0.879 (Öztürk et al., 2021). Each item is rated on a five-point Likert scale from 1 (Never) to 5 (Always). The overall score is calculated as the arithmetic mean of all items, where higher scores represent better chronic disease self-management and lower scores indicate poorer self-management (Öztürk et al., 2021).
At baseline (before the intervention) and at the end of week 6 (immediately after completion of the intervention).
Study Arms (2)
Video Education Group
EXPERIMENTALExperimental: Video Education Group Arm Description: Participants assigned to this arm received a six-week, home-based pulmonary rehabilitation self-management program delivered through animated educational videos. They were instructed to follow the program at least three times per week. The videos included respiratory education, correct inhaler technique, breathing exercises, airway clearance techniques, lower-extremity strengthening exercises, and nutritional recommendations.
Brochure Group
ACTIVE COMPARATORActive Comparator: Brochure Education Group Arm Description: Participants assigned to this arm received the same six-week, home-based pulmonary rehabilitation self-management program in an illustrated educational brochure. They were instructed to follow the program at least three times per week. The brochure included respiratory education, correct inhaler technique, breathing exercises, airway clearance techniques, lower-extremity strengthening exercises, and nutritional recommendations.
Interventions
All participants received an identical pulmonary rehabilitation self-management program delivered via animated educational videos for home-based use.
Participants received a home-based pulmonary rehabilitation self-management program in the form of an educational brochure covering disease management, exercise training, and family education
Eligibility Criteria
You may qualify if:
- Diagnosis of asthma according to the Global Initiative for Asthma (GINA) 2025 guidelines or chronic obstructive pulmonary disease (COPD) according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2026 guidelines Clinically stable while receiving medical treatment For participants with asthma, forced expiratory volume in 1 second (FEV₁) greater than 70% of the predicted value Ability to understand the study procedures and provide written informed consent
You may not qualify if:
- Clinically unstable respiratory condition or acute disease exacerbation Neuromuscular disease Unstable cardiovascular disease Musculoskeletal disorder that could limit participation in the exercise program Cognitive impairment or mental disorder that could interfere with communication or compliance with the study procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hatay Mustafa Kemal University
Antakya, Hatay, 31010, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- A Single-Assessor-Blinded
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof.
Study Record Dates
First Submitted
July 28, 2026
First Posted
August 3, 2026
Study Start
February 28, 2026
Primary Completion
June 1, 2026
Study Completion
June 30, 2026
Last Updated
August 3, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
The data that support the findings of this study are available from the corresponding author, \[İH\], upon reasonable request.